Gene · 887
Papers2,046
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,046
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Does Chronic Use of High Dose Proton Pump Inhibitors Increase Risk for Pancreatic Cancer? | Pancreas | 2022 | 37078934 | PubTator, text mining | PubMed |
| Elucidating the molecular determinants in the process of gastrin C-terminal pentapeptide amide end activating cholecystokinin 2 receptor by Gaussian accelerated molecular dynamics simulations. | Front Pharmacol | 2022 | 36756145 | PubTator, text mining | PubMed |
| CCKAR is a biomarker for prognosis and asynchronous brain metastasis of non-small cell lung cancer. | Front Oncol | 2022 | 36733361 | PubTator, text mining | PubMed |
| Use of proton pump inhibitors for the risk of gastric cancer. | Medicine (Baltimore) | 2022 | 36626449 | PubTator, text mining | PubMed |
| Targeting mTORC1 Activity to Improve Efficacy of Radioligand Therapy in Cancer. | Cancers (Basel) | 2022 | 36612012 | PubTator, text mining | PubMed |
| Elucidating the mechanism of Hongjinshen decoction in the treatment of pulmonary fibrosis based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36595795 | PubTator, text mining | PubMed |
| Identification and validation of critical genes with prognostic value in gastric cancer. | Front Cell Dev Biol | 2022 | 36589754 | PubTator, text mining | PubMed |
| Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice. | Pharmaceutics | 2022 | 36559317 | PubTator, text mining | PubMed |
| Introduction of a SiFA Moiety into the D-Glutamate Chain of DOTA-PP-F11N Results in Radiohybrid-Based CCK-2R-Targeted Compounds with Improved Pharmacokinetics In Vivo. | Pharmaceuticals (Basel) | 2022 | 36558917 | PubTator, text mining | PubMed |
| Functional and clinical characteristics of focal adhesion kinases in cancer progression. | Front Cell Dev Biol | 2022 | 36407100 | PubTator, text mining | PubMed |
| P2X7 Receptor in Alcoholic Steatohepatitis and Alcoholic Liver Fibrosis. | J Clin Transl Hepatol | 2022 | 36381094 | PubTator, text mining | PubMed |
| Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals. | Cancers (Basel) | 2022 | 36358776 | PubTator, text mining | PubMed |
| Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer. | Front Immunol | 2022 | 36341377 | PubTator, text mining | PubMed |
| Association between Serum Progastrin Biomarker Level and Gastric Cancer. | Asian Pac J Cancer Prev | 2022 | 36308387 | PubTator, text mining | PubMed |
| Celiac Disease and Gallbladder: Pathophysiological Aspects and Clinical Issues. | Nutrients | 2022 | 36297063 | PubTator, text mining | PubMed |
| CiberAMP: An R Package to Identify Differential mRNA Expression Linked to Somatic Copy Number Variations in Cancer Datasets. | Biology (Basel) | 2022 | 36290315 | PubTator, text mining | PubMed |
| The relationship of serum gastrin-17 and oral mucositis in head and neck carcinoma patients receiving radiotherapy. | Discov Oncol | 2022 | 36269422 | PubTator, text mining | PubMed |
| Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder. | Front Pharmacol | 2022 | 36263124 | PubTator, text mining | PubMed |
| Cholecystokinin Receptor Antagonist Suppresses Melanoma Growth by Inducing Apoptosis of Tumor Cells. | JID Innov | 2022 | 36262666 | PubTator, text mining | PubMed |
| Network Pharmacology and Molecular Docking Analyses Unveil the Mechanisms of Yiguanjian Decoction against Parkinson's Disease from Inner/Outer Brain Perspective. | Biomed Res Int | 2022 | 36237735 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/887/papers?page=11